Published in Journal of Nuclear Medicine · View the paper (DOI)
Researchers have developed a new PET imaging agent that targets NMDA receptors in nerve cells to assess treatments for various neurological diseases. The agent, C-Me-NB1, provides valuable insights into the role of NMDA receptors in brain disorders.
Coverage from 2 institutions